DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$0.76
-0.03 (-3.80%)
▼
5d:
-10.48%
30d:
-12.75%
90d:
-23.96%
HOLD
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $0.76, which is considered oversold relative to its 30-day fair value range of $0.81 to $0.92. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.2) compared to its historical average (6.8). Remarkably, the market is currently pricing in an annual earnings decline of 14.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: DH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.67 (+237.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DH is in a strong downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: DH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.67 (+237.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.81 -
$0.92
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 237.6% below Wall St target ($2.67)
- CAUTION: 5-day price weakness (-10.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.81 -
$0.92
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.83
Resistance Level
$1.01
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.22
Wall Street Target
$2.67
(+237.6%)
Revenue Growth (YoY)
-5.5%
Profit Margin
-71.5%
Valuation Discount vs History
-14.9% cheaper
PE vs Historical
4.2 vs 6.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.9%
(market-implied from PE analysis)
1-Year Target
$0.71
(-10%)
2-Year Target
$0.64
(-19%)
3-Year Target
$0.58
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→7)
$0.93
(+18%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 3.4%)
$4.52
(+472%)
Base:
(SPY PE: 4.2, Growth: 3.4%)
$0.87
(+11%)
Bear:
(PE: 3.6, Growth: 3.4%)
$0.74
(-6%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.2 to 6.8
Stabilization Target:
$1.27
(+61.3%)
PE Expansion Potential:
+61.3%
Share & Embed Analysis
Last updated: June 18, 2026 4:39 PM ET
Data refreshes hourly during market hours. Next update: 5:39 PM
Data refreshes hourly during market hours. Next update: 5:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 51 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 56 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 59 HOLD |
